Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

P Wang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5080933077. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 2

  1. Serum level of CCL2 predicts outcome of patients with pancreatic cancer. Co-author PMID 32603049↗
  2. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway. Last author DOI 10.1038/bjc.2015.102↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lu-Ming Liu · 1 shared paper, 2020 · strength 0.13
  2. Lanyun Feng · 1 shared paper, 2020 · strength 0.13
  3. Zhen Chen · 1 shared paper, 2020 · strength 0.13
  4. Zhiqiang Meng · 1 shared paper, 2020 · strength 0.13
  5. Qi Qi · 1 shared paper, 2020 · strength 0.13
  6. Zhengfei Zhu · 1 shared paper, 2015 · strength 0.06
  7. Jia Fan · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.